Federica Cappuccini
0000-0003-4124-1591
Publication & Citation Trends
Publications
0 total
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): a prospective cohort study.
Cited by 0
Semantic Scholar
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006).
Cited by 0
Semantic Scholar
Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil
Cited by 0
Semantic Scholar
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials OA
Cited by 13
Semantic Scholar
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus OA
Cited by 13
Semantic Scholar
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV OA
Cited by 37
Semantic Scholar
Abstract IA11: Viral vectored vaccines for prostate cancer
Cited by 0
Semantic Scholar
Research Topics
SARS-CoV-2 and COVID-19 Research
(19)
Immunotherapy and Immune Responses
(15)
COVID-19 Clinical Research Studies
(12)
Cancer Immunotherapy and Biomarkers
(8)
vaccines and immunoinformatics approaches
(6)
Affiliations
University of California, Irvine
Istituto Superiore di Sanità
Churchill Hospital
Helmholtz-Zentrum Dresden-Rossendorf
University of Oxford